Discover 1,244 paid clinical trials in Nashville, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Nashville offers many research opportunities for conditions such as diabetes, cardiovascular disease, and arthritis, giving participants access to innovative treatments and cutting-edge medical care. The city’s leading healthcare institutions are actively recruiting healthy volunteers for paid research studies, as well as individuals seeking trials for specific health concerns.
Filter
2
Filter results
Results: 1,244
Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC)
for
Atopic Keratoconjunctivitis
Location: Smyrna TN, Memphis TN, Saint Louis MO,
Sponsor: Andover Eye Associates
Sex: All
Age: 18+
Code: NCT04296864
Phase2, Recruiting
Care Transitions in Renal Disease Patients
for
Renal Disease
Location: Franklin TN
Sponsor: Fresenius Medical Care North America
Sex: All
Age: 18+
Code: NCT01842776
Recruiting
Phase 1 Study of ACR-2316 in Specific Advanced Solid Tumors
for
Specific Advanced Solid Tumors
Location: Franklin TN, Huntersville NC, Ann Arbor MI, Fairfax VA,
Sponsor: Acrivon Therapeutics
Sex: All
Age: 18+
Code: NCT06667141
Phase1, Recruiting
Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer
for
Prostate Cancer
Location: Nashville TN, Knoxville TN
Sponsor: Provision Center for Proton Therapy
Sex: Male
Age: 18+
Code: NCT02040610
Recruiting
A Study of MF101 in Postmenopausal Women
for
Hot Flushes, Vasomotor Symptoms
Location: Franklin TN, Smyrna TN, Jackson TN, Sandy Springs GA,
Sponsor: Bionovo
Sex: Female
Age: 40 - 65
Code: NCT00906308
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluate Umbilical Cord-derived Allogeneic Mesenchymal Stem Cells for the Treatment of Bradykinesia
for
Bradykinesia
Location: Brentwood TN, Paducah KY, Chesterfield MO
Sponsor: IMAC Holdings, Inc.
Sex: All
Age: 55+
Code: NCT04385056
Phase1, Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.